| 07:00 - 08:15 | 367 | CC6 Interstitial lung diseases | Challenging clinical cases |
| 07:00 - 08:15 | 368 | CC7 Severe asthma | Challenging clinical cases |
| 07:00 - 08:15 | 369 | CC8 Non-resolving pneumonia | Challenging clinical cases |
| 08:30 - 10:30 | 372 | Pulmonary endoscopy | Session |
| 08:30 - 10:30 | 373 | State of the art session: Respiratory critical care | Symposium |
| 08:30 - 10:30 | 374 | Proteases: at the cutting edge of lung disease | Symposium |
| 08:30 - 10:30 | 375 | GINA 2018 and beyond: shaping the future of asthma management | Symposium |
| 08:30 - 10:30 | 376 | Accelerated ageing in lungs | Symposium |
| 08:30 - 10:30 | 377 | Prenatal origins of respiratory and atopic disorders | Symposium |
| 08:30 - 10:30 | 378 | New perspectives on asthma, cough and laryngeal obstruction | Oral Presentation |
| 08:30 - 10:30 | 379 | Notable Studies in Asthma | Oral Presentation |
| 08:30 - 10:30 | 380 | Microorganisms and lung ecology: living in peace with bugs | Symposium |
| 08:30 - 10:30 | 381 | Biomarkers in COPD and asthma | Oral Presentation |
| 08:30 - 10:30 | 382 | New ideas about respiratory and sleep physiology in children | Oral Presentation |
| 08:30 - 10:30 | 383 | Acute pulmonary embolism: from diagnosis to treatment | Oral Presentation |
| 08:30 - 10:30 | 384 | Paediatric respiratory infections: translational and clinical perspectives | Oral Presentation |
| 08:30 - 10:30 | 385 | Interdependence of COPD and comorbidities and the underlying mechanisms | Poster Discussion |
| 08:30 - 10:30 | 386 | Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings | Oral Presentation |
| 08:30 - 10:30 | 387 | Additional latest insights in pulmonary rehabilitation for chronic lung diseases | Poster Discussion |
| 08:30 - 10:30 | 388 | CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside | Poster Discussion |
| 08:30 - 10:30 | 389 | Drug-resistant tuberculosis | Poster Discussion |
| 08:30 - 10:30 | 390 | Asthma analysis | Poster Discussion |
| 08:30 - 10:30 | 391 | Novel insights in the basic and translational research on idiopathic interstitial pneumonias | Poster Discussion |
| 10:45 - 12:45 | 398 | Pulmonary endoscopy | Session |
| 10:45 - 12:45 | 399 | Scientific Year in Review | Year in review |
| 10:45 - 12:45 | 400 | It's my favourite cell that affects your asthma | Symposium |
| 10:45 - 12:45 | 401 | Recent advances in respiratory disorders with oropharyngeal dysphagia | Hot topics |
| 10:45 - 12:45 | 402 | Fungal infection in the intensive care unit | Symposium |
| 10:45 - 12:45 | 403 | Recent advances in primary ciliary dyskinesia | Symposium |
| 10:45 - 12:45 | 404 | Quality, reference values and standards | Oral Presentation |
| 10:45 - 12:45 | 405 | Progress in rare interstitial lung diseases | Oral Presentation |
| 10:45 - 12:45 | 406 | New challenges in tackling known diseases with the 10 ERS Principles for Lung Health | Symposium |
| 10:45 - 12:45 | 407 | Imaging biomarkers and quantitative imaging | Oral Presentation |
| 10:45 - 12:45 | 408 | Pulmonary embolism: long-term sequelae and advances in therapies | Oral Presentation |
| 10:45 - 12:45 | 409 | Novel findings in biomarkers of tobacco use, exposure, hazards and genetics | Oral Presentation |
| 10:45 - 12:45 | 410 | CTD-ILD and hypersensitivity pneumonitis: risk stratification and management | Oral Presentation |
| 10:45 - 12:45 | 411 | Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings | Poster Discussion |
| 10:45 - 12:45 | 412 | General thoracic surgery | Oral Presentation |
| 10:45 - 12:45 | 413 | How far are we in terms of predicting mortality and exacerbations in COPD? | Poster Discussion |
| 10:45 - 12:45 | 414 | Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity | Poster Discussion |
| 10:45 - 12:45 | 415 | New insights in testing lung and respiratory muscle functions | Poster Discussion |
| 10:45 - 12:45 | 416 | Asthma and allergy in adults and children and their biomarkers | Poster Discussion |
| 10:45 - 12:45 | 417 | Pathobiology of pulmonary hypertension | Poster Discussion |
| 12:50 - 14:40 | 422 | Tests and trends in asthma | Thematic Poster |
| 12:50 - 14:40 | 423 | Asthma and drugs | Thematic Poster |
| 12:50 - 14:40 | 424 | Clinical markers of asthma | Thematic Poster |
| 12:50 - 14:40 | 425 | Patient-reported outcomes and scores in COPD | Thematic Poster |
| 12:50 - 14:40 | 426 | COPD and extrapulmonary comorbidities | Thematic Poster |
| 12:50 - 14:40 | 427 | Functional assessment of COPD | Thematic Poster |
| 12:50 - 14:40 | 428 | Biomarkers of COPD | Thematic Poster |
| 12:50 - 14:40 | 429 | COPD exacerbations and bronchiectasis | Thematic Poster |
| 12:50 - 14:40 | 430 | Sarcoidosis, interstitial lung diseases and various clinical problems | Thematic Poster |
| 12:50 - 14:40 | 431 | Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects | Thematic Poster |
| 12:50 - 14:40 | 432 | Aspects of pulmonary rehabilitation and chronic care | Thematic Poster |
| 12:50 - 14:40 | 433 | Use of stents for tracheal stenosis | Thematic Poster |
| 12:50 - 14:40 | 434 | Bronchoscopy and transthoracic ultrasound | Thematic Poster |
| 12:50 - 14:40 | 435 | Primary care management of asthma | Thematic Poster |
| 12:50 - 14:40 | 436 | Genetics in chronic pulmonary diseases | Thematic Poster |
| 12:50 - 14:40 | 437 | COPD: immune regulation and therapeutic targets | Thematic Poster |
| 12:50 - 14:40 | 438 | COPD: novel pathological mechanisms in the airway epithelium | Thematic Poster |
| 12:50 - 14:40 | 439 | Role of microbial exposure and inflammation in lung injury | Thematic Poster |
| 12:50 - 14:40 | 440 | Triggers of acute lung injury: mechanical ventilation and oxygen levels | Thematic Poster |
| 12:50 - 14:40 | 441 | Cardiovascular and metabolic consequences of sleep-disordered breathing | Thematic Poster |
| 12:50 - 14:40 | 442 | Treatments that can serve as an alternative to positive airway pressure (PAP) | Thematic Poster |
| 12:50 - 14:40 | 443 | Sleep and breathing control: phenotypes | Thematic Poster |
| 12:50 - 14:40 | 444 | COPD management | Thematic Poster |
| 12:50 - 14:40 | 445 | Studies on the mechanisms underlying airway disease | Thematic Poster |
| 12:50 - 14:40 | 446 | Airway disease: recent discoveries | Thematic Poster |
| 12:50 - 14:40 | 447 | Clinical and functional monitoring in airway disease | Thematic Poster |
| 12:50 - 14:40 | 448 | Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics | Thematic Poster |
| 12:50 - 14:40 | 449 | Epidemiology of asthma, COPD and factors that associate with lung function | Thematic Poster |
| 12:50 - 14:40 | 450 | Respiratory epidemiology: from infectious diseases to lung cancer | Thematic Poster |
| 12:50 - 14:40 | 451 | Occupational and environmental lung diseases: inhaled air quality and health effects | Thematic Poster |
| 12:50 - 14:40 | 452 | Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes | Thematic Poster |
| 12:50 - 14:40 | 453 | Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes | Thematic Poster |
| 12:50 - 14:40 | 454 | Improvements in the assessment of paediatric physiology | Thematic Poster |
| 12:50 - 14:40 | 455 | Paediatric asthma: new insights in its prevalence, treatment and treatment failure | Thematic Poster |
| 12:50 - 14:40 | 456 | Cystic fibrosis in paediatric patients: current research | Thematic Poster |
| 12:50 - 14:40 | 457 | Paediatric respiratory infections: mechanistic insights and clinical outcomes | Thematic Poster |
| 12:50 - 14:40 | 458 | Neonatology and paediatric intensive care | Thematic Poster |
| 12:50 - 14:40 | 459 | Insights in primary ciliary dyskinesia, asthma and lung function testing | Thematic Poster |
| 12:50 - 14:40 | 460 | Clinical challenges in respiratory infection | Thematic Poster |
| 12:50 - 14:40 | 461 | Difficult-to-treat respiratory infections | Thematic Poster |
| 12:50 - 14:40 | 462 | The immune response to tuberculosis: development of biomarkers and diagnostic tools | Thematic Poster |
| 12:50 - 14:40 | 463 | Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis | Thematic Poster |
| 12:50 - 14:40 | 464 | Diagnosis of tuberculosis | Thematic Poster |
| 12:50 - 14:40 | 465 | Management of idiopathic interstitial pneumonias: established and new treatments | Thematic Poster |
| 12:50 - 14:40 | 466 | Back to basics and translational research in idiopathic interstitial pneumonias | Thematic Poster |
| 13:00 - 14:30 | 467 | Bronchiectasis: new insights in diagnosis and treatment | Lunchtime session |
| 13:00 - 14:15 | 468 | Sleep and Breathing Disorders | Lungs on fire |
| 13:00 - 14:30 | 469 | Myths and Truths of Inhaler Technology | Lunchtime session |
| 13:00 - 14:00 | 471 | ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED | Meet the expert |
| 13:00 - 14:15 | 472 | Pulmonary Vascular Diseases & Respiratory Infections | Lungs on fire |
| 13:00 - 14:00 | 473 | ME11 Management of severe asthma in children FULLY BOOKED | Meet the expert |
| 13:00 - 14:00 | 474 | ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED | Meet the expert |
| 13:00 - 14:00 | 475 | ME12 Immunotherapies for lung cancer FULLY BOOKED | Meet the expert |
| 14:45 - 16:45 | 489 | Clinical Grand Round | Grand round |
| 14:45 - 16:45 | 490 | State of the art session: Interstitial lung diseases | Symposium |
| 14:45 - 16:45 | 491 | The digital ®evolution in respiratory medicine: a personalised approach? | Symposium |
| 14:45 - 16:45 | 492 | Pathophysiology of the human lung alveolus | Hot topics |
| 14:45 - 16:45 | 493 | Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? | Hot topics |
| 14:45 - 16:45 | 494 | Lung cancer screening and management of solitary pulmonary nodules | Symposium |
| 14:45 - 16:45 | 495 | Advanced profiling of immune cells in chronic lung diseases | Oral Presentation |
| 14:45 - 16:45 | 496 | Interventional pulmonology highlights in 2018: ELVR, TLD and BT | Oral Presentation |
| 14:45 - 16:45 | 497 | Malignant pleural effusions | Symposium |
| 14:45 - 16:45 | 498 | Chronic thromboembolic pulmonary hypertension | Oral Presentation |
| 14:45 - 16:45 | 499 | Bronchiectasis: phenotypes, endotypes and new therapies | Oral Presentation |
| 14:45 - 16:45 | 500 | Early Career Member: career and opportunities | Symposium |
| 14:45 - 16:45 | 501 | Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea | Oral Presentation |
| 14:45 - 16:45 | 502 | Disease exacerbations from a molecular point of view | Poster Discussion |
| 14:45 - 16:45 | 503 | Cystic fibrosis: diagnosis and monitoring | Oral Presentation |
| 14:45 - 16:45 | 504 | Understanding the immunopathology that underlies airway obstructive diseases | Poster Discussion |
| 14:45 - 16:45 | 505 | Primary ciliary dyskinesia and lung function tests in respiratory morbidities | Poster Discussion |
| 14:45 - 16:45 | 506 | Clinical determinants of asthma and biomarkers | Poster Discussion |
| 14:45 - 16:45 | 507 | Biomarkers and lung function in airway disease | Poster Discussion |
| 14:45 - 16:45 | 508 | Occupational and environmental lung diseases: air quality and lung damage | Poster Discussion |